Administration of anti-CD3 antibodies in the treatment of autoimmune diseases

Details for Australian Patent Application No. 2012201443 (hide)

Owner Glaxo Group Limited

Inventors Vaickus, Louis; Ponath, Paul; Rosenzweig, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2012201443

Parent 2007258694

Filing date 9 March 2012

Wipo publication date 5 April 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

29 March 2012 Complete Application Filed

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201444-Wind power prediction method of single wind turbine generator

2012201442-Retinal prosthesis with separate central electrode array and peripheral electrode array